Potential benefit of dolutegravir once daily: efficacy and safety

Overview of attention for article published in HIV/AIDS (Auckland, N.Z.), February 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 58 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

Dolutegravir-induced hand–foot skin reaction in a seropositive male: A rare presentation

Article in Indian Journal of Pharmacology (January 2024)

Comparative Safety and Changes in Immunologic and Virologic Parameters of Dolutegravir versus Efavirenz-Based Antiretroviral Therapies Among HIV Patients: A Retrospective Cohort Study

Article in HIV/AIDS - Research and Palliative Care (April 2023)

Current status of dolutegravir delivery systems for the treatment of HIV-1 infection

Article in Journal of Drug Delivery Science and Technology (October 2022)